SARS-CoV-2 (COVID-19) Nucleocapsid Antibody | 20-269

SARS-CoV-2 (COVID-19) Nucleocapsid Antibody | 20-269 | Gentaur UK, US & Europe Distribution

Host: Sheep

Reactivity: Virus

Homology: N/A

Immunogen: GST-SARS-CoV2 N Protein

Research Area: Infectious Disease, COVID-19

Tested Application: WB

Application: Detection Antibodies: 1 μg/ml Ab, 5% BSA in TBS-T, 4˚C overnight
Blocking: 5% milk in TBS-T, 1h room temp
Secondary Antibodies: 1:15, 000 donkey anti-sheep, 1:15, 000 donkey anti-rabbot, in TBS-T, 1h room temp
Wash: TBS-T, 4x 10 min

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Antibodies are affinity purified against the antigen and eluted with low pH.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Antibody supplied in PBS.

Concentration: batch dependent

Storage Condition: Aliquot and store at -20˚C. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Alternate Name: SARS-CoV-2-N Protein, SARS-CoV-2-Nucleocapsid Protein

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: N/A